Radiopharm Theranostics Stock Forecast

Stock Price Forecast

The 3 analysts that cover Radiopharm Theranostics stock have a consensus rating of "Strong Buy" and an average price target of $15, which forecasts a 224.68% increase in the stock price over the next year. The lowest target is $12 and the highest is $18.

Price Target: $15 (+224.68%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$15	$15	$18
Change	+159.74%	+224.68%	+224.68%	+289.61%

* Price targets were last updated on Jul 21, 2025.

Analyst Ratings

The average analyst rating for Radiopharm Theranostics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	3	3	3	3
Buy	0	0	0	0
Hold	0	0	0	0
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kemp Dolliver Brookline Capital	Brookline Capital	Strong Buy Initiates $18	Strong Buy	Initiates	$18	+289.61%	Jul 21, 2025
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy Initiates $12	Strong Buy	Initiates	$12	+159.74%	May 1, 2025
Yuan Zhi B. Riley Securities	B. Riley Securities	Strong Buy Initiates $15	Strong Buy	Initiates	$15	+224.68%	Mar 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.